Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Study on Difference Prognostic for Low Parathyroid Hormone Levels and Severe Secondary Hyperparathyroidism in Hemodialysis Patients

NCT03194087 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT03194087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03194087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Study on Difference Prognostic for Low Parathyroid Hormone Levels and Severe Secondary Hyperparathyroidism in Hemodialysis Patients
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
January 1, 2019
Enrollment
827 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism